Highest development stage: Phase 4

Gram-negative activity

Mechanism of Action/Target pathogen: Beta-Lactamase resistant. primarily for the treatment of multiple drug-resistant, Gram-Negative bacteria. Not active against Gram-positive bacteria or bacteria with altered penicillin-binding proteins